Cephalon demands secret patent-settlement info

Cephalon asked a U.S. judge to order the Federal Trade Commission to release confidential documents on drug patent-litigation settlements throughout the pharma industry, saying it needs the documents defend against an FTC lawsuit that seeks to clear generic competition for the company's top-selling narcolepsy treatment Provigil. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.